← back to search

William P. Weber

ETH Zurich · CH
Area of research
Organic Chemistry · Cancer Research
Research interest
Research interests include Breast Cancer Treatment Studies, Silicone and Siloxane Chemistry, Synthesis and characterization of novel inorganic/organometallic compounds, and Synthetic Organic Chemistry Methods.
h-index
57
citations
19,544
works
786
NIH funding
primary concept
email

Recent publications

Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study.
2025cited by 27position: contributordoi
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study
The Lancet Oncology 2025cited by 9position: middledoi
<i>TP53</i> Mutations and Phosphatidylinositol 3-Kinase/AKT Pathway Alterations Are Key Determinants of Breast Cancer Outcome Independent of Subtype and Stage.
2025cited by 2position: contributordoi
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy.
2024cited by 63position: contributordoi
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study
Journal of Clinical Oncology 2024cited by 38position: middledoi
Impact of Imaging-Guided Localization on Performance of Tailored Axillary Surgery in Patients with Clinically Node-Positive Breast Cancer: Prospective Cohort Study Within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
2024cited by 14position: contributordoi
Axillary Surgery for Breast Cancer in 2024.
2024cited by 13position: contributordoi
Targeted axillary dissection: worldwide variations in clinical practice.
2024cited by 8position: contributordoi
Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated Radiotherapy.
2024cited by 6position: contributordoi
Association of relative resection volume with patient-reported outcomes applying different levels of oncoplastic breast conserving surgery - A retrospective cohort study.
2024cited by 2position: contributordoi
Prognostic Importance of Axillary Lymph Node Response to Neoadjuvant Systemic Therapy on Axillary Surgery in Breast Cancer-A Single Center Experience.
2024cited by 2position: contributordoi
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)
Cancers 2023cited by 85position: middledoi
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer.
2023cited by 22position: contributordoi
Tailored axillary surgery - A novel concept for clinically node positive breast cancer.
2023cited by 21position: contributordoi
The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus
EClinicalMedicine 2023cited by 19position: middledoi
Use of sentinel lymph node biopsy in elderly patients with breast cancer - 10-year experience from a Swiss university hospital.
2023cited by 12position: contributordoi
Uncertainties and controversies in axillary management of patients with breast cancer.
2023cited by 10position: contributordoi
Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
2023cited by 8position: contributordoi
The American Society of Breast Surgeons classification system for oncoplastic breast conserving surgery independently predicts the risk of delayed wound healing.
2023cited by 4position: contributordoi
Discrepancy in Reporting of Perioperative Complications: A Retrospective Observational Study.
2023cited by 2position: contributordoi
Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event.
2023cited by 1position: contributordoi
The metastatic spread of breast cancer accelerates during sleep.
2022cited by 216position: contributordoi
Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy
The Breast 2022cited by 54position: firstdoi
Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy.
2022cited by 35position: contributordoi
Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
2022cited by 28position: contributordoi
Axillary surgery in node-positive breast cancer.
2022cited by 22position: contributordoi
The impact of delayed wound healing on patient-reported outcomes after breast cancer surgery.
2022cited by 11position: contributordoi
A high-throughput drug screen reveals means to differentiate triple-negative breast cancer.
2022cited by 11position: contributordoi
Comparison of patient-reported outcomes among different types of oncoplastic breast surgery procedures.
2022cited by 10position: contributordoi
The Role of HbA1c as a Positive Perioperative Predictor of Surgical Site and Other Postoperative Infections: An Explorative Analysis in Patients Undergoing Minor to Major Surgery.
2022cited by 7position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Florian Fitzal · Comprehensive Cancer Center Vienna13 papers (2017–2024)Viola Heinzelmann‐Schwarz · Roche (Switzerland)8 papers (2019–2025)Yves Harder · University Hospital of Lausanne6 papers (2020–2023)Charlotte K.Y. Ng · RWTH Aachen University6 papers (2019–2020)Salvatore Piscuoglio · University Hospital of Bern6 papers (2019–2022)Francesc Castro-Giner · University Hospital of Basel5 papers (2019–2022)Jens‐Uwe Blohmer · Berlin Institute of Health at Charité - Universitätsmedizin Berlin5 papers (2017–2022)Michael Gnant · Tolmar (United States)5 papers (2022–2024)Michael Golatta · University Medical Center Hamburg-Eppendorf4 papers (2019–2021)Christian Kurzeder · ETH Zurich3 papers (2017–2019)Christian Beisel · Board of the Swiss Federal Institutes of Technology3 papers (2019–2020)Nicola Aceto · The Geneva Association3 papers (2019–2022)Savas D. Soysal · University of St.Gallen3 papers (2017–2020)Nicola Aceto · ETH Zurich2 papers (2019–2019)Ramona Scherrer · Mentor2 papers (2019–2019)Joerg Heil · University of Lübeck2 papers (2020–2020)Mohamed Bentires-Alj · Friedrich Miescher Institute2 papers (2021–2022)Alexander Schmidt · University of Basel2 papers (2021–2022)Bernd Bodenmiller · Life Science Zurich2 papers (2019–2020)Priska Auf der Maur · TUM Klinikum2 papers (2021–2022)